What is the point of posting this, it is useless not only to the point of being ambiguous but also being counter productive. I have no problem hearing both sides of the equation, but your comments without data are just gossip.
I have been following the stock for about a year now and they have met everyone of the near term goals since then - FDA approval of CPI-300, commercialization partner w/ milestone payments / double digit royalties, commencement of the migraine clinical, ED work still on same timeline, etc.
Look forward to any information (+ or -) that I can check and verify.
News 
Market Data 
Discover 
